Caesarean Section and Intracytoplasmic Sperm Injection (ICSI) Outcome

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

March 15, 2023

Conditions
Female Infertility
Interventions
PROCEDURE

Frozen embryo transfer

All women in both groups will receive oral estradiol valerate 8 mg/ day from the second day of the menstrual cycle. Endometrial thickness will be assessed by vaginal ultrasonography at the tenth day of treatment. When endometrial thickness reached ≥ 7 mm all subjects, in addition to estrogen, they will receive progesterone vaginal suppositories 400 mg twice daily and 100 mg of progesterone intramuscularly daily. Frozen thawed embryo transfer will be at day 6 of progesterone. Estrogen and progesterone will be continued until 9-10 weeks of gestation

Trial Locations (1)

21131

Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER

NCT05528835 - Caesarean Section and Intracytoplasmic Sperm Injection (ICSI) Outcome | Biotech Hunter | Biotech Hunter